Geode Capital Management, LLC Sonoma Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.14 - $0.26 $7,120 - $13,224	50,864 Added 142.16%	86,644 $18,000
Q3 2023 Nov 13, 2023	SELL	$0.76 - $1.16 $329 - $503	-434 Reduced 1.2%	35,780 $27,000
Q1 2023 May 15, 2023	SELL	$0.94 - $2.02 $508 - $1,092	-541 Reduced 1.47%	36,214 $35,000
Q4 2022 Feb 13, 2023	SELL	$1.01 - $53.8 $124 - $6,617	-123 Reduced 0.33%	36,755 $41,000
Q3 2021 Nov 12, 2021	BUY	$5.23 - $8.89 $35,025 - $59,536	6,697 Added 22.19%	36,878 $205,000
Q2 2021 Aug 13, 2021	BUY	$7.12 - $9.15 $214,888 - $276,156	30,181 New	30,181 $221,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.84M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.